1. All Products
  2. DINJ - Injectable drugs
  3. HEPARIN sodium, 5 000 IU/ml, 5ml, amp.
Public Pricelist

HEPARIN sodium, 5 000 IU/ml, 5ml, amp.

https://medicalguidelines.msf.org/en/node/806
https://unicat.msf.org/cat/product/68709
STD DINJHEPA2A-

Valid Article

The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
10.2 - Medicines affecting coagulation
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
B01AB01
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
The product is part of at least one Kit. A kit is a collection of products (medical and/or logistic) that are needed for a certain intervention in emergency. The choice and quantity of the articles reflects the MSF protocols for this specific situation. The use of Kits allows to start an intervention without a detailed evaluation.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

HEPARIN sodium

Therapeutic Action

Anticoagulant

Indications

Venous and arterial thrombosis (pulmonary embolism, myocardial infarction, thrombophlebitis)

Prevention of venous and arterial thrombosis, especially in pre- and post-operative period and in patients on bedrest

Instructions for use

Administer by continuous IV infusion in 5% dextrose or 0.9% NaCl or
by intermittent IV injection, or by SC injection.

Closely monitor coagulation parameters and platelet.

Effects may be reversed by administration of protamine (specific heparin antagonist).

Benzyl alcohol-free formulation, preferred for paediatric use.

The ampoule presentation replaces the vial to provide benzyl alcohol-free heparin.

Precautions for Use

  • Avoid combination with aspirin, non-steroidal anti-inflammatory drugs (increased risk of haemorrhage).
  • Contra-indicated at the end of pregnancy (risk of haemorrhage during delivery).

Storage

Below 25°C - Protect from sunlight